EP-1495: Should we use correction factors for skin dose measurements with radiochromic films?

Should We Consider another Booster Dose of Measles Vaccine?

Background: To date, 36 years has passed since the beginning of measles vaccination; the disease is still circulating around the world, threatening lives of human beings especially in developing countries.  In recent years, we have confronted measles in previously vaccinated adults from all over the country. Objective: To find out if there is a need for changing our routine measles vaccination ...

Should we use a separate knife for the skin?

The aim of this study was to re-assess whether the use of a 'one-knife technique' can be considered as safe as the alternative practice of using separate skin and inside knives for elective orthopaedic surgery. A total of 609 knife blades from 203 elective orthopaedic operations, with equal numbers of skin, inside and control blades, were cultured using direct and enrichment media. We found 31 ...

Role of in vivo dosimetry with radiochromic films for dose verification during cutaneous radiation therapy

PURPOSE To evaluate the role of in vivo dosimetry with radiochromic films for dose verification in cutaneous radiation therapy (RT). METHODS Five patients with 8 cutaneous or sub-cutaneous malignancies of the face, neck, trunk and extremity receiving RT were included. Orthovoltage, megavoltage photon therapies were applied based on anatomic location. The delivered dose for each target was mea...

Skin Dosimetry in Radiotherapy of Breast Cancer: a Comparison between EBT and EBT3 Radiochromic Films

Objective: Radiochromic EBT3 film is a later generation of radiochromic films. The aim of this study is to compare EBT and EBT3 radiochromic films in radiotherapy fields of breast cancer.Methods: A RANDO phantom was irradiated by a 6 MV Siemens Primus linac with medial and lateral fields of radiotherapy of breast cancer. Dosimetry was performed in various points in the fields using EBT and EBT3...

5G Technology: Why Should We Expect a shift from RF-Induced Brain Cancers to Skin Cancers?